Aptar Pharma and MGH Collaborate to Advance Nose-to-Brain Drug Delivery

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Sep 14, 2026-

Aptar Pharma and MGH Collaborate to Advance Nose-to-Brain Drug Delivery

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, recently announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH) to advance the science of nose-to-brain (N2B) drug delivery. Aptar and its collaborators will develop an […]